0007-4642 : Promacta 75 mg Oral Tablet


NDC0007-4642
Labeler: Glaxosmithkline LLC
Product Type: Human Prescription Drug
Drug Name:  Promacta
Dosage Form: Oral Tablet, Film Coated
Application #: NDA022291
Rev. Date: 


Appearance:


Markings: GS;FFS;75
Shapes:  Round
Colors:  Pink / Red
Size (mm): 10
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

GS FFS 75: (0007-4642) Promacta 75 mg Oral Tablet by Glaxosmithkline LLC
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 0007-4642-13: 30 TABLET, FILM COATED IN 1 BOTTLE (0007‑4642‑13)

Active Ingredients:

  • Eltrombopag Olamine

Dosage Strength:

  • 75 mg

Inactive Ingredients:

  • Magnesium Stearate
  • Mannitol
  • Cellulose, Microcrystalline
  • Povidones
  • Sodium Starch Glycolate Type a Potato
  • Hypromelloses
  • Polyethylene Glycol 400
  • Titanium Dioxide
  • Ferric Oxide Red
  • Ferrosoferric Oxide

Pharmaceutical Classes:

  • Increased Megakaryocyte Maturation [PE]
  • Increased Platelet Production [PE]
  • Thrombopoietin Receptor Agonist [EPC]
  • Thrombopoietin Receptor Agonists [MoA]
  • Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]
  • Breast Cancer Resistance Protein Inhibitors [MoA]
  • UGT1A1 Inhibitors [MoA]
  • UGT1A3 Inhibitors [MoA]
  • UGT1A4 Inhibitors [MoA]
  • UGT1A6 Inhibitors [MoA]
  • UGT1A9 Inhibitors [MoA]
  • UGT2B7 Inhibitors [MoA]
  • UGT2B15 Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0007-4640 Promacta 25 mg Oral Tablet by Glaxosmithkline LLC
  • 0007-4641 Promacta 50 mg Oral Tablet by Glaxosmithkline LLC
  • 0007-4643 Promacta 12.5 mg Oral Tablet by Glaxosmithkline LLC
  • 0007-4644 Promacta 100 mg Oral Tablet by Glaxosmithkline LLC
  • 0007-4646 Promacta 100 mg/1 Oral Tablet, Film Coated by Glaxosmithkline LLC
  • 0078-0684 Promacta 12.5 mg Oral Tablet, Film Coated by Novartis Pharmaceuticals Corporation
  • 0078-0685 Promacta 25 mg Oral Tablet, Film Coated by Novartis Pharmaceuticals Corporation
  • 0078-0686 Promacta 50 mg Oral Tablet, Film Coated by Novartis Pharmaceuticals Corporation
  • 0078-0687 Promacta 75 mg Oral Tablet, Film Coated by Novartis Pharmaceuticals Corporation
  • 0078-0972 Promacta 12.5 mg Oral Powder, for Suspension by Novartis Pharmaceuticals Corporation

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0007-4642 QR Code

< Prev: 0007-4641Next: 0007-4643 >

Related Discussions:

Eltrombopag and amphetamines
Would like to know what happens if takentogether...
ciclopirox olamine
topical cream/ointment ## Information in box was not comprehensive enough. Had to go to internet to get the whole story.... 1 reply




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 July 2015.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA